GBA1 and Parkinson disease: Recent studies have revealed that GBA1 enzyme activity and the steady-state level of wild type GBA1 protein are both reduced in the postmortem of PD patients with and without GBA1 mutations [1, 2, 11, 31, 36], indicating the pivotal role of GBA1 on the development of sporadic PD.